Industries

Health Care

U.S. signs $450 million contract with Regeneron for COVID-19 therapy

U.S. signs $450 million contract with Regeneron for COVID-19 therapy

By: Manojna Maddipatla
Source: Reuters
Date of Publication: July 7th, 2020
The U.S. government signed a $450 million contract with Regeneron Pharmaceuticals Inc (REGN.O) for its potential COVID-19 antibody cocktail, the drugmaker said on Tuesday.
U.S. government awards Novavax $1.6 billion for coronavirus vaccine

U.S. government awards Novavax $1.6 billion for coronavirus vaccine

By: Julie Steenhuysen
Source: Reuters
Date of Publication: July 7th, 2020
The U.S. government has awarded Novavax Inc $1.6 billion to cover testing, commercialization and manufacturing of a potential coronavirus vaccine in the United States, with the aim of delivering 100 million doses by January 2021.
Gilead’s next COVID-19 treatment advancement could keep patients out of hospitals

Gilead’s next COVID-19 treatment advancement could keep patients out of hospitals

By: Sy Mukherjee
Source: Fortune
Date of Publication: June 22nd, 2020
Gilead won the first Food and Drug Administration (FDA) emergency authorization for a COVID-19 treatment in May. Now, the biotech giant says, it will soon begin clinical trials for a different version of the same experimental drug, remdesivir, which might make it easier to administer outside of a hospital or ICU wing.
Coronavirus pandemic threatens to delay potentially life-changing, new medicines

Coronavirus pandemic threatens to delay potentially life-changing, new medicines

By: Berkeley Lovelace Jr.
Source: CNBC
Date of Publication: June 19th, 2020
The coronavirus pandemic postponed the start of clinical trials for potentially life-changing, new medicines. It also could delay the time in which some of those drugs will reach the market as the U.S. Food and Drug Administration faces a potential surge in applications amid a pandemic. The full impact of the postponements for testing new drugs, treatments and vaccines for ailments besides Covid-19 may not be known for months.
CVS Reaches Goal To Open 1,000 Coronavirus Test Sites_Forbes

CVS Reaches Goal To Open 1,000 Coronavirus Test Sites

By: Bruce Japsen
Source: Forbes
Date of Publication: May 28th, 2020
CVS Health Thursday said it is delivering as promised to open 1,000 testing locations for the Coronavirus strain Covid-19.
TAGS:
Quest to Offer Employers Virus Tests to Help in Return to Work - Bloomberg

Quest to Offer Employers Virus Tests to Help in Return to Work

By: Emma Court
Source: Bloomberg
Date of Publication: May 27th, 2020
Quest Diagnostics Inc. is offering services to large employers geared at getting their employees back to work safely, including testing for the novel coronavirus, analytics to monitor symptoms and hotspots, and services like temperature monitoring, the company announced Wednesday.
J&J to begin human trials of COVID-19 vaccine in second half of July

J&J to begin human trials of COVID-19 vaccine in second half of July

By: Saumya Sibi Joseph
Source: Reuters
Date of Publication: June 10th, 2020
Johnson & Johnson said on Wednesday it would start human trials of its potential COVID-19 vaccine in the second half of July, two months earlier than planned, as drugmakers race to develop a shot for the deadly respiratory disease.
CEOs Call in the Coaches as Covid-19 Tests Their Companies_WSJ

CEOs Call in the Coaches as Covid-19 Tests Their Companies

By: Joann S. Lublin
Source: The Wall Street Journal
Date of Publication: May 27th, 2020
Business leaders with long-term leadership coaches say tough feedback has prepared them for the challenges of the pandemic.
AstraZeneca lays out plan for producing 2 billion doses of Covid-19 vaccine, if it works

AstraZeneca lays out plan for producing 2 billion doses of Covid-19 vaccine, if it works

By: Matthew Herper
Source: Stat News
Date of Publication: June 4th, 2020
The drug giant AstraZeneca said Thursday that it has found partners to manufacture and distribute 2 billion doses of the experimental Covid-19 vaccine created by Oxford University, inking a series of deals with non-government organizations and another manufacturer.
Coronavirus: AstraZeneca to begin making potential vaccine

Coronavirus: AstraZeneca to begin making potential vaccine

Source: BBC News
Date of Publication: June 5th, 2020
Drug company AstraZeneca is to start producing a potential vaccine for coronavirus, its boss has told the BBC.